
Smith+Nephew plc owns 1 brand in our database. Browse the complete portfolio of Smith+Nephew plc subsidiaries and brands across various industries.
Company Type
public
Headquarters
Watford, Hertfordshire, England
Brand Portfolio
1 brands
Is Smith+Nephew publicly traded?
Yes. Smith+Nephew plc is listed on the London Stock Exchange under ticker SN as a FTSE 100 company, with NYSE-traded ADRs under ticker SNN.
Who owns Smith+Nephew?
The company is independent, owned by its public shareholders. No parent company or controlling shareholder exists.
When was Smith+Nephew founded?
Thomas James Smith founded it in 1856 in Hull, England. It became T.J. Smith & Nephew when his nephew joined and incorporated in 1896.
How much revenue does Smith+Nephew make?
Smith+Nephew reported $6.16 billion in revenue for FY2025, spread across Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
Where is Smith+Nephew headquartered?
The company is headquartered in Watford, Hertfordshire, England, with major US operations in Memphis, Tennessee, and Andover, Massachusetts.
What does Smith+Nephew make?
Its products include hip and knee replacement implants, the CORI surgical robot, arthroscopy and ENT devices, and wound care products including Allevyn dressings and PICO negative-pressure therapy.
No competing brands found in the same categories. This could be because Smith+Nephew plcoperates in unique market segments or we're still building our competitor database.
Smith+Nephew plc maintains a diverse portfolio of 1 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Smith+Nephew plcprovides valuable insights into market dynamics, product relationships, and corporate strategy.